Molecure S.A. (MOC.WA)

PLN 10.0

(-1.96%)

Gross Profit Summary of Molecure S.A.

Molecure S.A.'s latest annual gross profit in 2023 was -4.1 Million PLN , down -7615.56% from previous year.
Molecure S.A.'s latest quarterly gross profit in 2024 Q3 was -716.97 Thousand PLN , up 9.17% from previous quarter.
Molecure S.A. reported a annual gross profit of -21.32 Thousand PLN in annual gross profit 2022, up 99.23% from previous year.
Molecure S.A. reported a annual gross profit of -2.77 Million PLN in annual gross profit 2021, down -103.28% from previous year.
Molecure S.A. reported a quarterly gross profit of -789.31 Thousand PLN for 2024 Q2, down -5.29% from previous quarter.
Molecure S.A. reported a quarterly gross profit of -749.68 Thousand PLN for 2024 Q1, down -136.3% from previous quarter.

Annual Gross Profit Chart of Molecure S.A. (2023 - 2015)

Historical Annual Gross Profit of Molecure S.A. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	-4.1 Million PLN	-7615.56%
2022	-21.32 Thousand PLN	99.23%
2021	-2.77 Million PLN	-103.28%
2020	84.53 Million PLN	58779.82%
2019	-144.05 Thousand PLN	1.81%
2018	-146.7 Thousand PLN	-48.28%
2017	-98.93 Thousand PLN	-96.91%
2016	-50.24 Thousand PLN	5.22%
2015	-53.01 Thousand PLN	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q3	-716.97 Thousand PLN	9.17%
2024 Q2	-789.31 Thousand PLN	-5.29%
2024 Q1	-749.68 Thousand PLN	-136.3%
2023 Q2	-461.09 Thousand PLN	-189.98%
2023 FY	-1.64 Million PLN	-7615.56%
2023 Q3	-98.67 Thousand PLN	78.6%
2023 Q4	2.06 Million PLN	2193.12%
2023 Q1	512.45 Thousand PLN	240.0%
2022 Q2	132.04 Thousand PLN	-67.37%
2022 Q4	-366.03 Thousand PLN	-90.61%
2022 FY	-21.32 Thousand PLN	99.23%
2022 Q1	404.68 Thousand PLN	212.94%
2022 Q3	-192.03 Thousand PLN	-245.43%
2021 Q4	129.31 Thousand PLN	159.84%
2021 FY	-2.77 Million PLN	-103.28%
2021 Q3	-216.12 Thousand PLN	73.82%
2021 Q2	-825.58 Thousand PLN	28.48%
2021 Q1	-1.15 Million PLN	-101.36%
2020 Q2	540.5 Thousand PLN	52.54%
2020 Q3	-27.78 Thousand PLN	-105.14%
2020 Q4	84.59 Million PLN	304533.91%
2020 FY	84.53 Million PLN	58779.82%
2020 Q1	354.34 Thousand PLN	1291.45%
2019 Q1	-57.04 Thousand PLN	-69.8%
2019 Q4	-29.74 Thousand PLN	-67.82%
2019 Q3	-17.72 Thousand PLN	55.18%
2019 Q2	-39.54 Thousand PLN	30.68%
2019 FY	-144.05 Thousand PLN	1.81%
2018 Q4	-33.59 Thousand PLN	-7.63%
2018 Q2	-38.09 Thousand PLN	13.02%
2018 Q1	-43.8 Thousand PLN	7.3%
2018 FY	-146.7 Thousand PLN	-48.28%
2018 Q3	-31.21 Thousand PLN	18.07%
2017 Q1	-19.05 Thousand PLN	-90.34%
2017 Q4	-47.25 Thousand PLN	-338.52%
2017 FY	-98.93 Thousand PLN	-96.91%
2017 Q3	-10.77 Thousand PLN	-103.76%
2017 Q2	286.26 Thousand PLN	1602.31%
2016 Q3	-10.32 Thousand PLN	-107.07%
2016 Q4	-10.01 Thousand PLN	3.06%
2016 FY	-50.24 Thousand PLN	5.22%
2016 Q1	146.15 Thousand PLN	0.0%
2016 Q2	146.15 Thousand PLN	0.0%
2015 FY	-53.01 Thousand PLN	0.0%

Peer Gross Profit Comparison of Molecure S.A.

Name	Gross Profit	Gross Profit Difference
Bioceltix S.A.	-1.03 Million PLN	-295.116%
BIOTON S.A.	72.85 Million PLN	105.63%
Captor Therapeutics Spolka Akcyjna	6.9 Million PLN	159.435%
Mabion S.A.	114.58 Million PLN	103.58%
NanoGroup S.A.	-79.01 Thousand PLN	-5090.793%
Pharmena S.A.	5.84 Million PLN	170.197%
Poltreg S.A.	-1.38 Million PLN	-195.718%
Pure Biologics Spólka Akcyjna	-2.57 Million PLN	-59.348%
Ryvu Therapeutics S.A.	29.3 Million PLN	113.996%
Synthaverse S.A.	35.16 Million PLN	111.663%
Urteste S.A.	-479 Thousand PLN	-756.286%